Clotrimazole: intermittent therapy in chronic mucocutaneous candidiasis.
Long-term intermittent therapy with the orally administered antifungal agent, clotrimazole, has not been reported previously. On the basis of experiences with our patient we propose that this is an effective way of treating chronic mucocutaneous candidiasis with a minimum of side effects.
D002179:Candidiasis, Cutaneous / Q000188:drug therapy*; D002180:Candidiasis, Oral / Q000188:drug therapy*; D002675:Child, Preschool; D003022:Clotrimazole / Q000008:administration & dosage* / Q000627:therapeutic use; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage*
D007093:Imidazoles; D003022:Clotrimazole